ToplineBrian Thompson—the 50-year-old CEO of the health insurance division of the $550 billion UnitedHealth Group—was killed Wednesday in what police believe was a targeted shooting in Manhattan ahead of an investor meeting.Brian Thompson, CEO of UnitedHealthcare. UnitedHealth Group Key FactsThompson, who worked for UnitedHealth for almost two decades before he was promoted to CEO of insurance unit UnitedHealthcare in 2021, was shot just before 7 a.m. outside of the company meeting at the New York Hilton Mi ...

Forbes Community GuidelinesOur community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.In order to do so, please follow the posting rules in our site's Terms of Service.  We've summarized some of those key rules below. Simply put, keep it civil.Your post will be rejected if we notice that it seems to contain:False or intentionally out-of-context or misleading informationSpamInsults, profanity, incoh ...

UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona on July 19, 2023.UnitedHealth Group on Wednesday canceled its investor day after reports that the CEO of its insurer unit, Brian Thompson, was fatally shot in Manhattan.Thompson led UnitedHealthcare, the largest private health insurer in the U.S. A spokesperson for the New York Police Department's Deputy Commissioner of Public Information confirmed that a 50-year-old male was shot in midtown Manhat ...

UnitedHealth Group (UNH) closed at $606.79 in the latest trading session, marking a +0.16% move from the prior day. This change lagged the S&P 500's 0.57% gain on the day. On the other hand, the Dow registered a gain of 0.28%, and the technology-centric Nasdaq increased by 0.63%.The largest U.S. health insurer's shares have seen an increase of 7.18% over the last month, surpassing the Medical sector's loss of 3.14% and the S&P 500's gain of 3.15%.Analysts and investors alike will be keeping a close eye on t ...

A federal judge in Texas recently ordered the Centers for Medicare and Medicaid Services (CMS) to recalculate UnitedHealth Group Incorporated’s (UNH) Medicare Star Ratings for the 2025 plan year. Jeremy Kernodle of the U.S. District Court for the Eastern District of Texas ruled in favor of UnitedHealthcare in its lawsuit against the CMS.The judge determined that CMS violated the Administrative Procedure Act of 1946 by incorrectly marking a test call to UnitedHealthcare's call center as unsuccessful, unfairl ...

As an investor, there are no investments that I appreciate more than undeniable dividend growth plays. I seek dominant businesses operating in markets with secular growth catalysts. Outside of Big Tech, there are almost no marketsHi, my name is Kody. Aside from my articles here on Seeking Alpha, I am also a regular contributor to TipRanks, Sure Dividend, and The Dividend Kings and iREIT+Hoya Capital. I have been investing since September 2017 and interested in dividend investing since about 2009.Since July ...

UnitedHealth Group (NYSE: UNH ) has slightly underperformed the broader market so far in 2024. The $553 billion market cap Health Care sector company sports a dividend yield about on par with the S&P 500, and investors are hopeful that a technical breakout thatFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. ...

Health insurance and healthcare delivery are supposed to be boring businesses right? Well, in theory, maybe, but in reality, this has been one of the most eventful landscapes I cover.I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on fundamentals, and hold them forever. I hope to publish articles covering such companies approximately 3 times per week, with extensive quarterly follow-ups and constant updates.I manage a concentrated portfolio targeted at ...

CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission on Tuesday, claiming that the agency's case against drug supply chain middlemen over high insulin prices in the U.S. is unconstitutional. The complaint, filed in the U.S. District Court for the Eastern District of Missouri, is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.The FTC in September sued CVS's Caremark, Cigna's Express Scripts and UnitedHealth's ...

Core Viewpoint - UnitedHealth Group Incorporated (UNH) has shown strong year-to-date performance, with a 12.7% increase, outperforming the industry average of 8.7% and significantly diverging from peers like Elevance Health and Humana, which saw declines of 13.7% and 38.2% respectively [1] Performance Comparison - UNH's stock is currently down 6% from its 52-week high of $630.73, while the S&P 500 Index has surged 25.9% during the same period [1] - The company's shares are trading at a forward 12-month price/earnings ratio of 19.88, higher than its five-year median of 19.14 and the industry average of 16.95, indicating a premium valuation [2] Growth Drivers - UnitedHealth's growth is supported by rising commercial membership in the domestic market, expansion in Optum Health's value-based care, and new client acquisitions for Optum Rx [4] - The company has demonstrated strong financial flexibility with operating cash flow increasing by 17.3% in 2022 and 10.9% in 2023, generating $21.8 billion in operating cash flows in the first nine months of 2024 [5] Shareholder Returns - In June 2024, UnitedHealth raised its quarterly dividend by 12% and returned $9.6 billion to shareholders through buybacks and dividends in the first nine months of 2024, with a dividend yield of 1.42% [6] Market Trends - The increase in healthcare spending in the U.S. is expected to benefit UnitedHealth, as it leverages its diverse offerings to mitigate margin pressures from slower private Medicare rate growth [7] - The divestiture of its Brazil operations is anticipated to enhance portfolio profitability in the long run [7] Diversification Strategies - UnitedHealth is diversifying into home healthcare and expanding its analytics business, focusing on AI-driven tools to improve efficiency and cut costs [8] Challenges - Rising medical costs, partly due to the pandemic, are expected to persist, impacting health insurers including UNH [9] - The company is also dealing with the fallout from a cyberattack on its Change Healthcare business, which has led to increased cybersecurity expenses and potential patient data protection violations [10] Earnings Estimates - There have been downward adjustments in earnings estimates for 2024 and 2025 due to the combined pressures from rising costs and the cyberattack [11] Long-term Outlook - Despite immediate challenges, UnitedHealth's scale, market expansions, and diversification strategies position it well for long-term growth, supporting the notion that its high valuation may be justified [14]